Архитектура Аудит Военная наука Иностранные языки Медицина Металлургия Метрология
Образование Политология Производство Психология Стандартизация Технологии


Е. Е. Петряйкина, Н. С. Рытикова. Диагностика сахарного диабета 1 и 2 типов. Лечащий врач, 2005. 5



 

Дедов И.И., Шестакова М.В., Сахарный диабет. Руководство для врачей. М. Издательство «Универсум Паблишинг», 2003, 455 с.

 

Бондарь Т.П., Козинец Г.И., Лабораторно-клиническая диагностика сахарного диабета и его осложнений. М.: Медицинское информационное агентство, 2003, - 88 с.: табл.

 

Уильямз Г., Пикап Д.К. Руководство по диабету. – М.МЕДпресс-информ. 2003, - 248 с., ил.

Цитированная литература

1. Pirart J. Diabetes mellitus and its degenerative complications: a prospec tive study of 4, 400 patients observed between 1947 and 1973 (part 1).Diabetes Care 1978; 1: 168­88.

 

2. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995; 18: 258­68.

 

3. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000 Aug 12; 321(7258): 405-412.

 

4. Krolewski AS, Laffel LM, Krolewski M, Quinn M, Warram JH. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin­dependent diabetes mellitus. N Engl J Med 1995; 332: 1251­125 5.

 

5. DCCT Research Group. The absence of a glycemic threshold for the development of long­term complications: the perspective of the diabetes control and complications trial. Diabetes 1996; 45: 1289­98

 

6. Orchard T, Forrest K, Ellis D, Becker D. Cumulative glycemic exposure and microvascular complications in insulin­dependent diabetes mellitus. Arch Intern Med 1997; 157: 1851­6.

 

7. Balkau B, Bertrais S, DucimitiË re P, EschwË ge E. Is there a glycemic threshold for mortality risk? Diabetes Care 1999; 22: 696­9.

 

8. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95, 783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 233­40.

 

9. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004; 141(6): 413-420.

 

10. Menon V, Greene T, Pereira AA, Wang X, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ. Glycosylated Hemoglobin and Mortality in Patients with Nondiabetic Chronic Kidney Disease. J Am Soc Nephrol 2005 16: 3411-3417

 

11. Nakanishi S, Yamada M, Hattori N, Suzuki G. Relationship between HbA(1)c and mortality in a Japanese population. Diabetologia. 2005; 48 (2): 230-234.

 

12. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH. Meta-analysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med, 2004, 141 (6) 421-431

13. Selvin E, Coresh J, Golden SH, Boland LL, Brancati FL, Steffes MW; Atherosclerosis risk in communities study. Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study. Diabetes Care. 2005, 28(8): 1965-1973.

 

14. Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, Steffes MW. Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med. 2005, 165(16): 1910-1916.

 

15. С.Н.Терещенко, Н.А.Джаиани, А.В.Голубев. Ишемическая болезнь сердца и сахарный диабет/ Consilium medicum 2005, 7, N 5.

16. Collins R, Armitage J, Parish S, Sleigh P, Peto R. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo controlled trial. Lancet 2003, 361: 2005–2016

 

17. Lyons TJ, Jenkins AJ. Lipoprotein glycation and its metabolic consequences. Curr Opin Lipidol 1997, 8: 174–180

 

18. Moro E, Alessandrini P, Zambon C, Pianetti S, Pais M, Cazzolato G, Bon GB Is glycation of low density lipoproteins in patients with type 2 diabetes mellitus a LDL pre-oxidative condition? Diabet Med 1999, 16: 663–669

 

19. Witztum JL, Mahoney EM, Branks MJ, Fisher M, Elam R, Steinberg D. Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes. 1982 31: 283–291

 

20. Scheffer P. G.. Teerlink T.. Heine R. J Clinical significance of the physicochemical properties of LDL in type 2 diabetes. Diabetologia (2005) 48: 808

 

21. Veiraiah A. Hyperglycemia, lipoprotein glycation, and vascular disease. Angiology. 2005; 56(4): 431-438

 

22. Ostgren CJ, Lindblad U, Ranstam J, Melander A, Rastam L (2002) Glycaemic control, disease duration and beta-cell function in patients with Type 2 diabetes in a Swedish community. Skaraborg Hypertension and Diabetes Project. Diabet Med 19: 125–129

 

23. Lehto S, Ronnemaa T, , Pyorala K, Laakso M. Predictors of stroke in middle­aged patients with non­insulin­dependent diabetes. Stroke 1996; 27: 63­8.

 

24. Kothari V, Stevens RJ, Adler AI, Stratton IM, Manley SE, Neil HA, Holman RR. UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke. 2002; 33 (7): 1776-1781.

 

25. Stevens RJ, Coleman RL, Adler AI, Stratton IM, Matthews DR, Holman RR Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66. Diabetes Care. 2004; 27(1): 201-207

 

26. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13 000 men and women with 20 years of follow-up. Arch Intern Med,  2004; 164: 1422–26

 

27. Bravata DM, Wells CK, Kernan WN, Concato J, Brass LM, Gulanski BI. Association between impaired insulin sensitivity and stroke. Neuroepidemiology. 2005; 25(2): 69-74

 

28. Stevens RJ, Coleman RL, Adler AI, Stratton IM, Matthews DR, Holman RR Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66. Diabetes Care. 2004; 27(1): 201-207

 

29. Selvin E, Coresh J, Shahar E, Zhang L, Steffes M, Sharrett AR. Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Lancet Neurol. 2005; 4(12): 821-826. 

 

30. Skyler JS. Diabetic complications. The importance of glucose control. Endocrinol Metab Clin North Am. 1996; 25(2): 243-254     

 

31. Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR. UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care. 2002; 25(5): 894-899

 

32. Bakker SJ, Gansevoort RT, Stuveling EM, Gans RO, de Zeeuw D. Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk? Curr Hypertens Rep. 2005; 7(5): 379-84

33. Greene MF, Hare JW, Cloherty JP, Benacerraf BR, Soeldner JS. First-trimester hemoglobin A1 and the risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology 1989; 39: 225-31.

 

34. The Diabetes and Pregnancy Group, France. French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 2003; 26: 2990-3.

 

35. Evers IM, de Valk HW, Visser GHA. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 2004; 328: 915-918.

36. Radder JK, van Roosmalen J. HbA1c in healthy, pregnant women. Neth J Med. 2005; 63(7): 256-259.

 

37. Hu FB, Manson JA, Liu S, Hunte D, Coldit GA, Michel KB, Speize FE, Giovannucci E

Prospective Study of Adult Onset Diabetes Mellitus (Type 2) and Risk of Colorectal Cancer in Women/ J Natl Cancer Inst, 1999, 91, 6, 542-547.

 

38. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev. 2004; 13(6): 915-919.  

ЗАО «ДИАКОН»  предлагает:


Поделиться:



Последнее изменение этой страницы: 2019-05-04; Просмотров: 280; Нарушение авторского права страницы


lektsia.com 2007 - 2024 год. Все материалы представленные на сайте исключительно с целью ознакомления читателями и не преследуют коммерческих целей или нарушение авторских прав! (0.014 с.)
Главная | Случайная страница | Обратная связь